Fundraising FoxHeartland
Family officeBrande · Growth
Find your way into Heartland
Sign up to find every way you can get introduced to Heartland
- Your email: who you already know at Heartland, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Heartland team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Heartland invests with a long-term orientation enabled by its family-owned structure, which lets it avoid short-term compromises. The firm prioritizes people, mindset, and values alongside a clear vision and solid business plan, seeking to transform promising ideas into meaningful ventures while preserving enduring value. It fosters long-term relationships as a core part of its approach and invests with genuine commitment and integrity.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 6 of 6 portfolio companiesCleantech ×2Climate Tech ×2Deep Tech ×2Energy ×2Advanced Manufacturing ×1AI & Machine Learning ×1Biotech ×1Fintech ×1
HQs:Denmark×3United States×2United Kingdom×1
Investments · 6 tracked
founders shown can be your intro pathBy year:2025 · 12023 · 12018 · 13 dated
miRagen Therapeutics is a biopharmaceutical company developing monoclonal antibodies and other engineered protein therapeutics targeting specific receptors (IGF-1R, FcRn, and TSHR) for autoimmune and rare diseases including thyroid eye disease, Graves' disease, and various autoimmune conditions.
BiotechBoulder, US
William S. Marshall(Executive Officer, Director)Jason A. Leverone(Executive Officer)inDavid Rodman(Executive Officer)Stephen Mahoney(President, Chief Executive Officer and Director)Thomas Beetham(Chief Operating Officer)inRadhika Tripuraneni(Chief Medical Officer)in
Co-investorsBrace PharmaBroadview VenturesMC Healthcare VenturesRidgeback CapitalAtlas VentureBoulder Ventures+1 more
Kvasir Technologies develops biofuel technology that converts non-edible lignocellulosic biomass (such as straw, wood chips, and corn stover) into biocrude and drop-in bio-oil that can replace marine heavy fuel oil.
CleantechClimate TechDeep TechEnergyCopenhagen, DK
Joachim Bachmann Nielsen(CEO & Co-founder)inAnders Bak Kristoffersen(Co-Founder)
Co-investorsThe Footprint FirmVÅR VenturesMaersk Growth
Funding Circle is an online lender that provides business financing products including term loans, flexible credit lines, and business credit cards to small businesses in the UK.
FintechLondon, GB
Andrew Mullinger(Founder)James Meekings(Founder)Samir Desai(Founder)
Co-investorsAccelIndex VenturesPerscitus LLPPrime VenturesUnion Square Ventures (USV)Montage Ventures+1 more
Laborup uses AI to match skilled manufacturing workers with industrial companies seeking to hire, reducing hiring costs and time-to-fill for roles in machining, welding, and production.
Advanced ManufacturingAI & Machine LearningFuture of WorkHR TechTennessee, US
Simba J.(Founder)in
Co-investorsHeartland VenturesHeartland Ventures S7Market Square VenturesMarketplaceNKECHI IREGBULEMNVP Capital+9 more
Landfolk is a curated marketplace for booking handpicked holiday homes with distinctive character and design.
MarketplacesTravel & HospitalityÅrhus, DK
Christian Schwarz Lausten(Founder)inAnders Boelskifte Mogensen(Founder)inCamilla Swartz(Founder)inCathrine K. Reimann(Founder)inChris Kjær Sørensen(Founder)inLars Kloster Silkjær(Founder)in
Co-investorsSEED Capital DenmarkSeed Capital Limited
Saltfoss (formerly Seaborg Technologies) develops floating nuclear power plants designed for deployment in coastal and remote regions.
CleantechClimate TechDeep TechEnergyCopenhagen, DK
Andreas Vigand Schofield(Chief Technical Officer & Co-founder)inEsben Klinkby(Vice President R&D Partnering & Co-founder)in
Co-investorsUnruly Capital
Exits · 2
2 IPOs · showing 1miRagen TherapeuticsNASDAQ: VRDN
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| miRagen Therapeutics | 2.7% | $2.80 | Feb 2015 | $536.8K |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- How many investments has Heartland made?
- Heartland has 6 tracked investments, 2 of which have exited, including 1 dated in the last 24 months.
- What stage does Heartland invest at?
- Heartland invests at the Growth stage.
- What sectors does Heartland focus on?
- Heartland focuses on Climate Tech, Consumer, Crypto & Web3.
- Where is Heartland located?
- Heartland is headquartered in Brande, DK.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Union Square Ventures is a New York-based venture capital firm that invests across a broad range of technology sectors, presenting a large portfolio spanning crypto, fintech, climate, AI, education, health, and marketplaces.
Openspace is a multi-strategy asset manager focused on Southeast Asia that partners with portfolio companies across sectors, often from early stages such as Series A.
Addition is a venture capital firm that invests in early and growth-stage tech companies.